Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_leftBack to Achieverx.com
Achieve Life Sciences, Inc. IR Overview
  • Overview
  • News & Events
    • News & Events Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Information
    • Company Information Overview
    • Management Team
    • Contacts
  • Financial Information
    • Financial Information Overview
    • Financial Results
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • SEC Filings Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Corporate Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Information
  • Stock Information
  • chevron_leftBack to Achieverx.com

Press Releases

News & Events

  • News & Events Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Jan 24, 2018 5:30 am EST
Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories
Nov 28, 2017 5:30 am EST
Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation
Nov 14, 2017 5:30 am EST
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects
Nov 9, 2017 4:05 pm EST
Achieve Reports Financial Results for Third Quarter 2017
Nov 8, 2017 5:30 am EST
Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017
Nov 6, 2017 8:31 am EST
Achieve Announces Availability of Company Presentation from the Virtual Investor Conference
Oct 30, 2017 8:31 am EDT
Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017
Oct 26, 2017 5:30 am EDT
Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine
Oct 4, 2017 5:30 am EDT
Achieve Announces Advancement of Cytisine Clinical Development Program
Sep 14, 2017 4:05 pm EDT
Achieve Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
Achieve Life Sciences ™

US Headquarters

22722 29th Dr. SE, Suite 100 Bothell, WA 98021 Phone: 425-686-1500

California Office

150 Mathilda Place, Suite 102 Sunnyvale, California 94086

Vancouver Office

1040 West Georgia Street, Suite 1030 Vancouver, BC V6E 4H1

Social

  • LinkedIn
  • X
  • Home
  • About
  • Pipeline
  • Investors
  • News
  • Careers
  • Contact

© Copyright 2026 | Achieve Life Sciences, Inc. All Rights Reserved

  • Privacy Policy
  • Terms & Conditions
  • Contact
  • References

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.